3,4-DIHYDRO-1H-ISOQUINOLOIN-2-YL-DERIVATIVES

摘要

The present invention relates to novel compounds of formula I wherein the variable groups are as defined in the claims or a pharmaceutically acceptable acid addition salt thereof. The compounds of the invention are NK2 antagonists.